Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1864

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351864)

Label (Lbl713351864)
This information is not enough to generate a useful description. The provided text includes a drug name 'Venlafaxine,' its dosage, and a caution about the effect on drowsiness. It also contains information about the manufacturer, dosage recommendations, and expiration date. However, there is no clear context or topic to elaborate on this information.*
FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
This is a report on the interacting drug Cimetane and its effect on three analytes named "aniatxine", "veniatxine", and "venistaxing." The report suggests that Cimetane may cause an increase in the maximum plasma concentration (Cmax) of the analytes, and it advises that caution be exercised in using Cimetane with patients who have hypertension, or hepatic dysfunction. However, the clinical significance of these interactions is unknown, so further monitoring is recommended. The report also lists PK fold changes relative to the reference value for each of the three analytes.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

FDA Label Image

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.